NCT03994003View on ClinicalTrials.gov

BIO-PREDISC-TIA SWISS Cohort Study

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

August 4, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions
Cerebrovascular Disease, Ischemic Stroke
Trial Locations (2)

1011

Centre hospitalier Vaudois, Lausanne

6900

Ospedale Regionale di Lugano, Lugano

All Listed Sponsors
collaborator

Ente Ospedaliero Cantonale, Bellinzona

OTHER

lead

Dr. med. Carlo Cereda

OTHER_GOV

NCT03994003 - BIO-PREDISC-TIA SWISS Cohort Study | Biotech Hunter | Biotech Hunter